Thursday, December 19, 2024
HomeTagsCardio-Metabolic Disorders

Cardio-Metabolic Disorders

Rivus Pharmaceuticals Closes $132 Million Series B Financing to Advance HU6 for the Treatment

Rivus Pharmaceuticals Inc., a clinical-stage biopharmaceutical company dedicated to improving cardio-metabolic health, announced the completion of a $132 million Series B financing led by...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics